AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06572202 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology Intervention
Description: The 14-session intervention program is designed to enhance various internal resiliency factors. It begins with an orientation to positive psychology and setting group guidelines. Cognitive resilience is developed through identifying personal and signature strengths, reappraising memories, and learning savoring techniques. Emotional resilience is strengthened by focusing on forgiveness, managing decision fatigue, and fostering positive communication. Spiritual resilience is cultivated through gratitude practices and exploring hope and optimism. Behavioral resilience is addressed by recognizing strengths in others and engaging in altruism. The final session integrates all these elements to promote lasting positive changes in engagement, relationships, meaning, and accomplishments. Mid-session feedback ensures the program's effectiveness and responsiveness to participants' needs.
Study NCT05981365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: Drug drug interaction
Study NCT05981365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Drug drug interaction
Study NCT05981365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Drug drug interaction
Study NCT05981365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: Drug drug interaction
Study NCT05981365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Drug drug interaction
Study NCT06572917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin
Description: Single dose of 0.1 mg/kg dose intravenous indomethacin as a slow infusion over 20 mins
Study NCT06572917 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dose of intravenous normal saline placebo as a slow infusion over 20 mins
Study NCT06574256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chemotherapy symptom Management Online Education
Description: Randomization was achieved and data collection began. Patients were given the Chemotherapy Symptom Management Education Booklet and were informed that they would be contacted by phone.~In the second and third stages of data collection, they were called by phone on the 7th day after receiving chemotherapy treatment. The symptoms experienced by the patient were evaluated with the N-SDS and the quality of life was evaluated with the EORTC QLQ-C30. Online nursing education videos were sent to the women in the intervention group regarding the symptoms they experienced. The practices they performed from the suggestions in the education videos and education booklets sent were recorded on the nurse follow-up form.~In the fourth stage, the practices specified in the third stage were repeated on the 7th day after the third chemotherapy course, and at this stage, the satisfaction of the women in the intervention group with the online education was evaluated.
Study NCT06572761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of antibiotics
Description: Ceftriaxone : 1g/day parenteral clarithromycin 500 mg\*2/day orally metronidazole 500mg\*3/ day orally
Study NCT06572761 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Emergency cerclage
Description: Emergency cerclage
Study NCT06572761 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Emergency cerclage
Description: Emergency cerclage
Study NCT06572761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Description: Vaginal progesterone
Study NCT06572761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal progesterone
Description: Vaginal progesterone
Study NCT06573047 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: kinesotape
Description: a- Kinesio-tape: cure tape (made in Korea) made from 100% gentle cotton fibre and 100% medical grade acrylic adhesive. its Hypoallergenic, water-resistant and does not limit range of motion (ROM), it is come with different colours and sizes. Kinesio Tape is safe enough for a baby's sensitive skin, and gentle enough for aging individuals, flexible enough for rehabilitation, durable enough to support working muscle, joint or ligament and strong enough for athletes at any level.
Study NCT06573047 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Chest physiotherapy exercises
Description: selected chest physiotherapy exercise three times per week for two weeks, each session will be about 20 minute which will include the following exercise ( huffing , coughing , percussion,and postural drainage)
Study NCT04755660 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise behavior change for resistance exercise
Description: The intervention includes motivational interviews and self-efficacy theory-based exercise behavior and home-based resistance exercise intervention (by Elastic Band or non- Elastic Band ), and 3 follow-up telephone calls. The usual care group will receive exercise counseling.
Study NCT04755660 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise behavior change for resistance exercise
Description: The intervention includes motivational interviews and self-efficacy theory-based exercise behavior and home-based resistance exercise intervention (by Elastic Band or non- Elastic Band ), and 3 follow-up telephone calls. The usual care group will receive exercise counseling.
Study NCT04755660 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Exercise behavior change for resistance exercise
Description: The intervention includes motivational interviews and self-efficacy theory-based exercise behavior and home-based resistance exercise intervention (by Elastic Band or non- Elastic Band ), and 3 follow-up telephone calls. The usual care group will receive exercise counseling.
Study NCT05557279 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 500 mg NDS-446
Description: All participants will receive 500 mg NDS-446 daily for 12 weeks following a baseline assessment
Study NCT06118086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REM-422
Description: * REM-422 is a first in class, small molecule mRNA inhibitor that reduces expression of the MYB transcription factor~* REM-422 will be administered orally once daily
Study NCT05544877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated 5-day Gratitude Exercise and Behavioral Activation Program
Description: The 5-day intervention integrates a brief behavioral activation (BA) and a gratefulness exercise (GE) program. BA is composed of a lab-based idea generation and planning phase as well as a home-based performing phase with regard to pleasurable activities. GE is a idea generation task about aspects in life participants are grateful for about. It is performed once lab-based and daily with a home-based diary.
Study NCT05794893 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Good Behavior Game
Description: Universal school-based intervention reinforcing prosocial behaviors and discouraging disruptive behaviors in young students.
Study NCT06255730 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate Ganglion Block
Description: the patients in the observation group were provided with Stellate Ganglion Block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate Ganglion Block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06490224 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Relevant Patient Reported Outcome Measures (PROMs)
Description: Depending on the participant's complaint: Hip disability and osteoarthritis outcome score JR (HOOS JR), Knee disability and osteoarthritis outcome score JR (KOOS JR), Quick Disabilities of the Arm, Shoulder, and Hand, Quick Disabilities of the Arm, Shoulder, and Hand (QUICKDASH), Patient Health Questionnaire 9 (PHQ-9), General Anxiety Disorder-7 (GAD7), Patient Self-Efficacy Questionnaire (PSEQ-2), Patient-Reported Outcomes Measurement Information System (PROMIS Global 10)
Study NCT06490224 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevant Patient Reported Outcome Measures (PROMs)
Description: Depending on the participant's complaint: Hip disability and osteoarthritis outcome score JR (HOOS JR), Knee disability and osteoarthritis outcome score JR (KOOS JR), Quick Disabilities of the Arm, Shoulder, and Hand, Quick Disabilities of the Arm, Shoulder, and Hand (QUICKDASH), Patient Health Questionnaire 9 (PHQ-9), General Anxiety Disorder-7 (GAD7), Patient Self-Efficacy Questionnaire (PSEQ-2), Patient-Reported Outcomes Measurement Information System (PROMIS Global 10)
Study NCT06490224 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: My Whole Health Map
Description: Short visual map of responses to 10 questions of subjective measures.
Study NCT05638126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1780 table or placebo
Description: HRS-1780 table or placebo single dose
Study NCT05638126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1780 table or placebo
Description: HRS-1780 table or placebo single dose with food effect
Study NCT05638126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1780 table or placebo
Description: HRS-1780 table or placebo multiple dose
Study NCT06577818 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CC+SI (Chest compression during sustained inflation)
Description: CC+SI (Chest compression during sustained inflation)
Study NCT06577818 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3:1 C:V (3:1 Compression:Ventilation ratio)
Description: 3:1 C:V Group (Control group - Standard of Care): Newborns randomized to 3:1 C:V will receive a CC rate of 90/min and 30 ventilations/min as per current resuscitation guidelines. The PIP used for the 30 inflations will also be 30cmH2O) as per current resuscitation guidelines. Every 60sec, a HR assessment as per neonatal guidelines will be performed to assess if HR is \<60/min - continue CC or >60/min - stop CC (current standard of care). 3:1 C:V will be continued until ROSC.
Study NCT06575205 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational video
Description: Participants will view a brief 3-to-5-minute educational video (VIDEO), covering information that is already printed on FDA labels for OTC NSAIDs, on their own device covering themes such as: defining OTC NSAIDs, potential harms of NSAIDs, and alternatives.
Study NCT06344884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early catheter removal
Description: Catheter removal the day after surgery as opposed to standard of care (3 to 4 days after surgery)
Study NCT05544877 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Integrated 5-day Gratitude Exercise and Behavioral Activation Program
Description: The 5-day intervention integrates a brief behavioral activation (BA) and a gratefulness exercise (GE) program. BA is composed of a lab-based idea generation and planning phase as well as a home-based performing phase with regard to pleasurable activities. GE is a idea generation task about aspects in life participants are grateful for about. It is performed once lab-based and daily with a home-based diary.
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efprezimod alfa
Description: IV infusion: 480 mg at Day -1, 240 mg at Day 14, 240 mg at Day 28.
Study NCT06255730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: the patients in the observation group were provided with Stellate Ganglion Block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate Ganglion Block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06222398 — intervention group
Intervention type: DEVICE
Intervention: Exoskeleton
Description: The study will include one group of patients who are current exoskeleton users.
Study NCT04785378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medical mask
Description: Participants will carry out field tests one day wearing a medical mask and the other day without a mask.
Study NCT04785378 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Field tests
Description: Participants will perform 6 MWT and ISWT tests to determine their exercise capacity, and a 30-second sit and stand test to determine lower extremity endurance.
Study NCT05831878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab vedotin
Description: 2.0mg/kg, iv, day1, every 2 weeks
Study NCT06320184 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial Intelligence risk model
Description: Combining blood-based biomarkers, radiologic parameters, clinical features, and AI tools to create a robust model to predict lung cancer risk.
Study NCT05693259 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrolyzed Alkaline Reduced Water (EARW) generated from electrolyzed ionizer
Description: Patient will be allocated randomly to two groups: EARW and PW groups. For 6 weeks, patients drink water (10mL/kg body weight/day ) generated from the device installed in the house before starting intervention. Patients will be instructed to drink in empty stomach, and to drink immediately after generation of water. The total amount that the patient drank the day before will be monitored by a researcher using survey form of mobile phone everyday.
Study NCT05693259 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Electrolyzed Alkaline Reduced Water (EARW) generated from electrolyzed ionizer
Description: Patient will be allocated randomly to two groups: EARW and PW groups. For 6 weeks, patients drink water (10mL/kg body weight/day ) generated from the device installed in the house before starting intervention. Patients will be instructed to drink in empty stomach, and to drink immediately after generation of water. The total amount that the patient drank the day before will be monitored by a researcher using survey form of mobile phone everyday.
Study NCT06140537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: Dapagliflozin 10mg orally daily
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion, 100 ml at Day -1, Day 14, and Day 28.
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: IV, 15 mg/m\^2/dose at Day 1, then 10 mg/m2/dose at Day 3, 6, 11.
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methotrexate
Description: IV, 15 mg/m\^2/dose at Day 1, then 10 mg/m2/dose at Day 3, 6, 11.
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Begin on day -3. IV \[0.03 mg/kg/day\] or PO \[0.045 mg/kg/dose\] dosing is permitted
Study NCT04095858 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tacrolimus
Description: Begin on day -3. IV \[0.03 mg/kg/day\] or PO \[0.045 mg/kg/dose\] dosing is permitted
Study NCT05740930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partition defocus myopia management spectacle lens
Description: Participants in the intervention group will receive the partition defocus myopia management spectacles lens and receive follow-up checks.
Study NCT05740930 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spectacle lenses with aspherical lenslets
Description: Participants in the control group will receive the spectacle lenses with aspherical lenslets and receive follow-up checks.
Study NCT05226130 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cervical transcutaneous vagus nerve stimulation (active comparator)
Description: Active nVNS produces low-voltage electrical signal that generates sensations on the skin on upper anterior cervical area (overlying carotid artery) and that stimulates the vagus nerve.
Study NCT05226130 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Cervical transcutaneous vagus nerve stimulation (sham comparator)
Description: Sham nVNS produces low-voltage electrical signal that generates sensations on the skin on upper anterior cervical area (overlying carotid artery) and that does not stimulate the vagus nerve.
Study NCT06532045 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Description: TENS applied for 30 min for each time, five times a week, for 2 weeks and deep breathing relaxation exercise given to the intervention group twice a day (10min/exercise) for two weeks.
Study NCT06532045 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Description: TENS applied for 30 min for each time, five times a week, for 2 weeks and deep breathing relaxation exercise given to the intervention group twice a day (10min/exercise) for two weeks.
Study NCT05257889 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood and CSF studies + neuroimaging studies
Description: blood and CSF studies + neuroimaging studies
Study NCT05747677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HH-120 Nasal Spray
Description: HH-120 nasal spray, 1 spray to each nostril of the participant each time,8-10 times per day, until the discharge of the SARS-CoV-2 infected patients or confirmed infection of the participant, whichever occurs first.
Study NCT05278949 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: The surgical intervention
Description: The participant's primary IOL is re-fixed without utilizing any new material.
Study NCT05368805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Fruquintinib will be administered as a single oral 5mg dose on the morning of day 5
Study NCT05368805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran Etexilate
Description: Dabigatran Etexilate will be administered as a single oral dose 150mg on the morning of day 1 and morning of day 5
Study NCT05368805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin will be administered as a single oral dose 10mg on the morning of day 1 and the morning of day 5
Study NCT05793905 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Buffered lidocaine in inferior alveolar nerve block injection
Description: Buffered Lidocaine 2% with epinephrine 1.80000 mixed with 1.8% sodium bicarbonate in IANB injection in the treatment of bilateral primary mandibular molars
Study NCT05793905 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: lidocaine 2% in inferior alveolar nerve block injection
Description: Lidocaine 2% with epinephrine 1.80000 in IANB injection in the treatment of bilateral primary mandibular molars
Study NCT05436574 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dance therapy
Description: Before/after study to measure the effects of the dance therapy activity on the quality of life of the elderly population housed in the establishments of UNIVI group.
Study NCT06446635 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Semiflex Dome Catheter System
Description: Abces: In patients that present with a perianal abscess/sinus the semiflex dome catheter is inserted under general anesthesia. A small cut is made to drain and irrigate the septic sinus.~Fistula: Under general anesthesia the seton is removed, the internal opening is excised and the internal opening is closed with a 2-0 Vicryl cross stitch.~Both: Before surgery, the length of the tract is measured on MRI or CT. A Semiflex Catheter with the appropriate length and a diameter is selected. If during surgery appears that this is not the appropriate size, a different size catheter can be used. The catheter is fixed on a Renasys Adhesive gel patch (Smith and Nephew). The catheter is connected with a tubing system to a vacuum pomp with an average vacuum pressure of 80 cm H2O. The tube will be taped on the patient. After every 2-3 days the catheter will be exchanged by a 3-6 mm shorter catheter.
Study NCT05306652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised physical activity
Description: patients will have a home-based physical activity prescription, defined on the functional endurance and strength tests and they will be supervised for 3 months. Once monthly they will be examined by the oncologist (visit and questionnaires) and at weeks 4, 6, 8, 10 and 12 at the sport medicine center where the three tests will be repeated. Home-based activity will be monitored daily through a specific application. Endurance improvement is defined as an increase in walking speed; strength improvement is defined as an increase of the number of repetitions
Study NCT05306652 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unsupervised physical activity
Description: patients will receive a physical activity counselling, without a real prescription and supervision, and the three test will be repeated once a month for three months at the local sport medicine center and at the oncology center (visit and questionnaires). Counselling will include general informations on physical exercise
Study NCT05729074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment
Description: Drug: IN-A002 Ointment 0.3%, 10 g/1000 cm2 Drug: IN-A002 Placebo Ointment, 10 g/1000 cm2